These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 25141897

  • 1. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C, Peters B, Mitropoulou C, Mitropoulos K, Katsila T, Agarwal MR, van Schaik RH, Drmanac R, Borg J, Patrinos GP.
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [Abstract] [Full Text] [Related]

  • 2. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
    Low SK, Takahashi A, Mushiroda T, Kubo M.
    Clin Cancer Res; 2014 May 15; 20(10):2541-52. PubMed ID: 24831277
    [Abstract] [Full Text] [Related]

  • 3. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W, Zhou HH.
    Yao Xue Xue Bao; 2011 Jan 15; 46(1):1-5. PubMed ID: 21465801
    [Abstract] [Full Text] [Related]

  • 4. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L, Siest G, Jeannesson E, Visvikis-Siest S.
    Pharmacogenomics; 2011 May 15; 12(5):681-91. PubMed ID: 21619430
    [Abstract] [Full Text] [Related]

  • 5. One size fits one: pharmacogenetics in gastroenterology.
    Porayette P, Flockhart D, Gupta SK.
    Clin Gastroenterol Hepatol; 2014 Apr 15; 12(4):565-70. PubMed ID: 24486737
    [Abstract] [Full Text] [Related]

  • 6. Pharmacogenomics: historical perspective and current status.
    Charlab R, Zhang L.
    Methods Mol Biol; 2013 Apr 15; 1015():3-22. PubMed ID: 23824846
    [Abstract] [Full Text] [Related]

  • 7. Pharmacogenomics--10 years of progress: a cardiovascular perspective.
    Winkelmann BR, Herrington D.
    Pharmacogenomics; 2010 May 15; 11(5):613-6. PubMed ID: 20415546
    [Abstract] [Full Text] [Related]

  • 8. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
    Becquemont L.
    Pharmacogenomics; 2009 Jun 15; 10(6):961-9. PubMed ID: 19530963
    [Abstract] [Full Text] [Related]

  • 9. Pharmacogenetics of second-generation antipsychotics.
    Brennan MD.
    Pharmacogenomics; 2014 Apr 15; 15(6):869-84. PubMed ID: 24897292
    [Abstract] [Full Text] [Related]

  • 10. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
    Wei CY, Lee MT, Chen YT.
    Hum Mol Genet; 2012 Oct 15; 21(R1):R58-65. PubMed ID: 22907657
    [Abstract] [Full Text] [Related]

  • 11. Personalized medicine - the promised land: are we there yet?
    Li C.
    Clin Genet; 2011 May 15; 79(5):403-12. PubMed ID: 21204795
    [Abstract] [Full Text] [Related]

  • 12. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
    Zaza G, Granata S, Mangino M, Grandaliano G, Schena FP.
    G Ital Nefrol; 2010 May 15; 27(4):353-66. PubMed ID: 20672232
    [Abstract] [Full Text] [Related]

  • 13. Pharmacogenetic content of commercial genome-wide genotyping arrays.
    Lemieux Perreault LP, Zaïd N, Cameron M, Mongrain I, Dubé MP.
    Pharmacogenomics; 2018 Oct 15; 19(15):1159-1167. PubMed ID: 30272537
    [Abstract] [Full Text] [Related]

  • 14. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].
    Mushiroda T.
    Rinsho Byori; 2013 May 15; 61(5):422-7. PubMed ID: 23947182
    [Abstract] [Full Text] [Related]

  • 15. Whole-genome sequencing in pharmacogenetics.
    Urban TJ.
    Pharmacogenomics; 2013 Mar 15; 14(4):345-8. PubMed ID: 23438878
    [No Abstract] [Full Text] [Related]

  • 16. Clinical association between pharmacogenomics and adverse drug reactions.
    Zhou ZW, Chen XW, Sneed KB, Yang YX, Zhang X, He ZX, Chow K, Yang T, Duan W, Zhou SF.
    Drugs; 2015 Apr 15; 75(6):589-631. PubMed ID: 25895462
    [Abstract] [Full Text] [Related]

  • 17. Pharmacogenomics of the response to IFN-beta in multiple sclerosis: ramifications from the first genome-wide screen.
    Vandenbroeck K, Matute C.
    Pharmacogenomics; 2008 May 15; 9(5):639-45. PubMed ID: 18466107
    [Abstract] [Full Text] [Related]

  • 18. Biomarkers and personalized therapy in chronic kidney diseases.
    Schena FP.
    Expert Opin Investig Drugs; 2014 Aug 15; 23(8):1051-4. PubMed ID: 24857812
    [Abstract] [Full Text] [Related]

  • 19. Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment.
    Drögemöller BI, Wright GE, Niehaus DJ, Emsley R, Warnich L.
    Pharmacogenet Genomics; 2013 Dec 15; 23(12):666-74. PubMed ID: 24141736
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacogenomics].
    Nakatani K, Nobori T.
    Rinsho Byori; 2013 Nov 15; 61(11):1018-25. PubMed ID: 24450107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.